Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy.

Détails

ID Serval
serval:BIB_B77754D94784
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy.
Périodique
Nature Medicine
Auteur⸱e⸱s
Fleury S., de Boer R.J., Rizzardi G.P., Wolthers K.C., Otto S.A., Welbon C.C., Graziosi C., Knabenhans C., Soudeyns H., Bart P.A., Gallant S., Corpataux J.M., Gillet M., Meylan P., Schnyder P., Meuwly J.Y., Spreen W., Glauser M.P., Miedema F., Pantaleo G.
ISSN
1078-8956
Statut éditorial
Publié
Date de publication
1998
Peer-reviewed
Oui
Volume
4
Numéro
7
Pages
794-801
Langue
anglais
Notes
Journal Article Research Support, Non-U.S. Gov't --- Old month value: Jul
Résumé
We show that the fraction of proliferating CD4+ lymphocytes is similar in HIV-infected subjects in the early stage of disease and in HIV-negative subjects, whereas the fraction of proliferating CD8+ lymphocytes is increased 6.8-fold in HIV-infected subjects. After initiation of antiviral therapy, there is a late increase in proliferating CD4+ T cells associated with the restoration of CD4+ T-cell counts. These results provide strong support for the idea of limited CD4+ T-cell renewal in the early stage of HIV infection and indicate that after effective suppression of virus replication, the mechanisms of CD4+ T-cell production are still functional in early HIV infection.
Mots-clé
Adult, Aged, Anti-HIV Agents, CD4-CD8 Ratio, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, Carbamates, Cell Division, Dideoxynucleosides, Drug Therapy, Combination, Female, HIV Infections, HIV Protease Inhibitors, Humans, Ki-67 Antigen, Lymph Nodes, Male, Middle Aged, Reverse Transcriptase Inhibitors, Sulfonamides
Pubmed
Web of science
Création de la notice
28/01/2008 9:59
Dernière modification de la notice
20/08/2019 16:25
Données d'usage